Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer

18 May 2023

Abstract excerpt

Objective: To explore the relationship between flavin-containing monooxygenases (FMOs) and peritoneal metastasis (PM) in gastric cancer (GC). Materials and methods: TIMER 2.0 was used to perform pan-cancer analysis and assess the correlation between the expression of FMOs and cancers. A dataset from The Cancer Genome Atlas (TCGA) was used to analyze the correlation between FMOs and clinicopathological features of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Inflammatory mediators and NSAID effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37274237
DOI: 10.3389/fonc.2023.1144775

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancerPMID 37274237Read ↗

Construction of a nomogram model for predicting peritoneal metastasis in gastric cancer based on ferroptosis-relate genes and clinicopathological featuresSemantic proximity Read ↗

Analysis of ROMO1 Expression Levels and its Oncogenic Role in Gastrointestinal Tract CancersSemantic proximity Read ↗

MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and ExperimentsSemantic proximity Read ↗

RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.Semantic proximity Read ↗

Effects of Helicobacter pylori on the expression of the FTO gene and its biological role in gastric cancerSemantic proximity Read ↗

Olfm4 Is Highly Expressed In Liver Cancer Patients And As A Biomarker And Therapeutic Target For Liver CancerSemantic proximity Read ↗

Identification of Key Gene and Pathways for the Prediction of Peritoneal Metastasis of Gastric Cancer by Co-expression AnalysisSemantic proximity Read ↗

Gene expression and prognosis of NOX family members in gastric cancerSemantic proximity Read ↗

HMOX1 promotes lung adenocarcinoma metastasis by affecting macrophages and mitochondrion complexesSemantic proximity Read ↗

Clinicopathological and prognostic value of Lysyl oxidase expression in gastric cancer: a meta-analysis and bioinformatics analysisSemantic proximity Read ↗

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancerSemantic proximity Read ↗

N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.